Versartis

PharmaceuticalsSeries ERedwood City, USversartis.com

Latest round

Series E

Last raised

Feb 2014

Total raised

$113M

Investors

7

About Versartis

Versartis, Inc.Founded in 2008 in Redwood City, US, Versartis, Inc. specializes in developing treatments for growth hormone deficiency.Versartis, Inc. primarily offers therapeutic solutions aimed at addressing growth hormone deficiencies. Their flagship product focuses on enhancing growth hormone levels in affected patients, with applications in both pediatric and adult populations.In the most recent year, 2017, Versartis, Inc. aims to expand its product offerings and enter new markets within the biopharmaceutical sector. The company plans to invest in the development of additional therapies aimed at addressing growth disorders while seeking to penetrate emerging markets in Asia and Europe by 2025. The funds from the IPO will be utilized to support these initiatives, ensuring continued growth and innovation in their therapeutic portfolio.

Who invested in Versartis

7 investors across 6 rounds

See all investors in Versartis

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Feb 18, 2014

    Amount

    $55M

    Investors

    Locked

  2. Series D

    Feb 4, 2014

    Amount

    $10M

    Investors

    Locked

  3. Series D

    Oct 10, 2013

    Amount

    $10M

    Investors

    Locked

  4. Series C

    Jan 25, 2013

    Amount

    $13M

    Investors

    Locked

  5. Series B

    Feb 16, 2011

    Amount

    $14M

    Investors

    Locked

  6. Series A

    Jun 2, 2009

    Amount

    $11M

    Investors

    Locked

Questions about Versartis

Who invested in Versartis?

Versartis has 7 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Versartis raised?

Versartis has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did Versartis last raise money?

Versartis's most recent round on record is a Series E, in Feb 2014.

What does Versartis do?

Versartis is a pharmaceuticals company.

Where is Versartis headquartered?

Versartis is headquartered in Redwood City, US.

Which VCs invest in companies like Versartis?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Versartis's stage. Their profiles are linked below.

Raising like Versartis? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.